Promotion of non-evidence based tests and treatments using empowerment messages risks women being overdiagnosed and overtreated, argue Tessa Copp and colleagues
Commercial organisations have an extraordinary influence on population health through how they engage with and shape social movements to market their products.1 Corporations have historically exploited health agendas by prioritising messaging about female autonomy to encourage women’s consumption of unhealthy commodities, such as tobacco and alcohol.2 This phenomenon has now expanded across women’s health. Feminist narratives of increasing women’s autonomy and empowerment regarding their healthcare, which first arose through early women’s health movements,34 are now increasingly adopted by commercial entities to market new interventions (technologies, tests, treatments) that lack robust evidence or ignore the evidence that is available.
Increased awareness and advocacy in women’s health are vital to overcome sex in
Australia
Ireland
United-kingdom
Irish
Australian
Kirsten-mccaffery
Leah-hardiman
Jenna-smith
Sweekriti-sharma
Minna-johansson
Ray-moynihan
Shannon-mckinn